Kopran Ltd

KOPRAN

Company Profile

  • Business description

    Kopran Ltd is an Indian pharmaceutical company with integrated operations across formulations and Active Pharmaceutical Ingredients (APIs). The company is engaged in the development, manufacturing and marketing of pharmaceutical products for both domestic and international markets. Its formulations business focuses on oral solid dosage forms and other pharmaceutical products across a range of therapeutic categories. The API business manufactures a portfolio of APIs and intermediates. Its portfolio spans therapeutic areas such as anti-infectives, cardiovascular, gastroenterology, CNS and anti-diabetic products, along with specialized APIs including Atenolol and Sterile Carbapenems. It operates in a single reportable segment of the manufacturing of Formulation (Finished Dosage Form).

  • Contact

    Dr. E. Moses Road
    1076, Parijat House
    Worli
    MumbaiMH400 018
    IND

    T: +91 2243661111

    https://www.kopran.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 March 2027

    Employees

    1,156

Stocks News & Analysis

stocks

This Cheap ASX REIT may be overlooked

Takeover strengthens portfolio outlook for ASX REIT.
stocks

Do AI labs like Anthropic and OpenAI have economic moats?

Leading AI labs are building economic moats to stave off commodification threats.
stocks

12 picks for an income portfolio - Q3 2026 update

Passive income growth continues to be strong but two picks are facing challenges.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,937.0059.300.67%
CAC 407,825.0021.670.28%
DAX 4025,251.36164.090.65%
Dow JONES (US)51,654.95423.310.83%
FTSE 10010,629.6377.580.74%
HKSE24,271.2059.850.25%
NASDAQ27,366.17172.830.64%
Nikkei 22569,030.9211.19-0.02%
NZX 50 Index13,827.6278.270.57%
S&P 5007,811.5446.180.59%
S&P/ASX 2008,783.2066.600.76%
SSE Composite Index3,797.2416.55-0.43%

Market Movers